| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |